GISP/eGISP Clinical/Demongraphic (Epi) Data Dictionary/Elements {24DS}

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name
PATIENT_ID

Type/Length
[Char, 18]

Description
Patient ID

Values
#######

Comments
An eGISP patient identifier should be created which
is unique within the jurisdiction, remain consistent
across visits and the life cycle of eGISP, and not
contain personally identifiable information (PII).

eGISP_SPEC_ID

[Char, 18]

eGISP/SURRG ID

e.g., CHICC170107918.

For all isolates collected, sites should assign and
maintain an eGISP/SURRG specimen ID for all
isolates, constructed using the 3 letter sentinel site
code + local PHL accession number (no hyphens or
spaces).

SPECIMEN_TYPE

[Char, 2]

Anatomic site of
specimen collection

U=urethral
V=vaginal
E=endocervical
R=rectal
P=pharyngeal
NC=not captured

NAAT_GC

[Char, 1]

Nucleic acid
amplification test
(NAAT) result

1=positive
2=negative
3=indeterminate/ equivocal
9=unknown

POSSIBLE_NM

[Char, 1]

Isolate suspected to
be N. meningitidis

1=isolate may be N. meningitides
2=isolate has been positively identified
as N. gonorrhoeae

A possible N. meningitidis isolate is considered
when an isolate has (i) the growth of typical
appearing N. gonorrhoeae colonies with typical
morphologies (e.g., small, transparent) on a
selective medium such as Thayer-Martin at 35o C to
36.5o C in 5% CO2, (ii) a positive oxidase test, (iii)
the observation of Gram-negative, oxidase-positive
diplococci in stained smears and (iv) a negative
NAAT result.
If additional testing is performed to confirm the
species of the isolate, this information can also be
used to make a determination.

Page 1

Revised January 2021

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name
NmVacc

Type/Length
[Char, 1]

Description
Prior history of
meningococcal
vaccination

Values
1= MenACWY vaccine only
2= MenB vaccine only
3= Men ACWY + MenB vaccine
4= Meningococcal/meningitis vaccine,
but unknown
5= No meningitis vaccine
9= Unknown

CLINIC

[Char, 3]

Sentinel site code

ALB = Albuquerque
ANC= Anchorage
BAL= Baltimore
BHM=Birmingham
BUF= Buffalo
CAM= Camden
CHI=Chicago
CLE = Cleveland
COL=Columbus
DAL=Dallas
DEN=Denver
FSM =Federated States of Micronesia
GRB=Greensboro
HON=Honolulu
IND=Indianapolis
JAC= Jackson
KCY=Kansas City
LVG=Las Vegas
LA1/LA2=Los Angeles
MIA=Miami
MIL=Milwaukee
MIN=Minneapolis
NOR=New Orleans
NYC= New York City
ORA=Orange County
PHI=Philadelphia
PHX=Phoenix
PON=Pontiac
POR=Portland
SDG=San Diego
SEA= Seattle
SFO=San Francisco

Page 2

Comments
There are several vaccines for meningitis available.
The MenACWY vaccines are called Menactra or
Menveo. MenB vaccines are called Trumenba and
Bexsero. If it is known that a patient has received no
meningococcal vaccine, please mark “No meningitis
vaccine”. Otherwise mark “unknown”.

Revised January 2021

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name

Type/Length

Description

Values
TRP=Tripler
WDC= Washington, DC

Comments

CLINID

[Char, 1]

Clinic identifier
number

1, 2, 3…9

For Sentinel Sites using more than one clinic to
collect the eGISP samples, the clinic code should be
entered here. Each clinic is assigned a single-digit
code by the Sentinel Site; codes and the
corresponding clinic names should be given to the
eGISP data manager. Any changes in participating
clinics should be communicated to the eGISP data
manager.

GISP_SPEC_ID

[Char, 13]

GISP ID

e.g., NYC-201703-07

To maintain consistency for sentinel sites who are
also funded for GISP activities, isolates from the
first 25 male patients with gonococcal urethritis will
be considered “GISP isolates”; therefore, eGISP
sites that are also GISP sites should assign and
maintain a GISP ID locally constructed by
concatenating the variables of sentinel site
code+year month+GISP isolate ID number,
separated by hyphens.

PATIENT_GENDER

[Char, 1]

Patient Gender

1=male
2=female
3=trans male
4=trans female
5=non-binary/trans other
9=unknown

ETHNIC

[Char, 1]

Hispanic

1=Hispanic or Latino
2=not Hispanic or Latino
9=unknown

Page 3

This question pertains to patients of Hispanic origin
and/or native Spanish speakers. If this information
is solicited for the patient's record, please code
accordingly. Do not assume a patient's ethnicity
based on surname alone, as people can change their
names, be adopted, etc. Use only self-reported
ethnic status. Furthermore, note that race and
ethnicity are not mutually exclusive variables.
Individuals who indicate their ethnicity as
"Hispanic" are not necessarily "white." If the
information is unavailable, please code this item "9"

Revised January 2021

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name

Type/Length

Description

Values

AMIND

[Char, 1]

American Indian/
Alaskan Native

1=yes, 2=no, 9=unknown

ASIAN

[Char, 1]

Asian

1=yes, 2=no, 9=unknown

BLACK

[Char, 1]

Black

1=yes, 2=no, 9=unknown

NAHAW

[Char, 1]

Native Hawaiian/
Pacific Islander

1=yes, 2=no, 9=unknown

WHITE

[Char, 1]

White

1=yes, 2=no, 9=unknown

ORACE

[Char, 1]

Other race

1=yes, 2=no, 9=unknown

DATEVIS

[Date]

Date of clinic visit

MM/DD/YYYY

AGE

[Num, 2]

Age in years

1, 2, 3…98
99=unknown

CISFEM

[Char, 1]

Cis female partners

1=yes, 2=no, 9=unknown

CISMALE

[Char, 1]

Cis male partners

1=yes, 2=no, 9=unknown

TRANSFEM

[Char, 1]

Trans female
partners

1=yes, 2=no, 9=unknown

TRANSMALE

[Char, 1]

Trans male partners

1=yes, 2=no, 9=unknown

UNKFEM

[Char, 1]

Female partners
(unknown gender)

1=yes, 2=no, 9=unknown

Page 4

Comments
to indicate "unknown." If the patient is described as
"Hispanic" with no accompanying race data, please
code "1" for ethnicity.
It is important to be as precise as possible with
regard to demographic data as it may be used as an
indicator of, or proxy for, other variables affecting
morbidity outcomes such as socioeconomic status.
We realize that data on race may not be collected at
each site; however, where the information is
available, please use the following guidelines in
coding these data. Self-reported race status is
considered to be the most valid. If race is not selfreported in the clinic record, but is noted by the
clinician, this information may be used. If there is a
conflict between the two, e.g., the patient selfreports that racial status is "white," but the clinician
describes patient as "black," use the self-reported
status. You should respond "yes" for all race
categories that apply.
Enter the month, day, and year of the clinic visit at
which the positive gonorrhea culture was obtained.
If the day is unknown, enter "01" for day. The year
and month should correspond to the year and month
entered for item 2 above.

Gender of the patient’s sexual partners within
the past 3 months. You should respond "yes" for
all gender categories that apply.
In clinics where gender of sex partner is not directly
ascertained from the patient, you should respond
“yes” for “female partners (unknown gender)”
and/or “male partners (unknown gender)” categories
that apply. In clinics where sex or gender of sex
partner is not directly ascertained from the patient,
code "9" for "unknown" in the cis and trans partner
categories.

Revised January 2021

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name
UNKMALE

Type/Length
[Char, 1]

Description
Male partners
(unknown gender)

Values
1=yes, 2=no, 9=unknown

Comments

SYMP

[Char, 1]

Presence of
gonorrhea
symptom(s) at
anatomic site of
isolate

1=symptoms present
2=no symptoms present
9=unknown

This question pertains to the presence of symptoms
of gonorrhea at the genital and/or extra-genital site
where the isolate was collected. Symptoms of
gonorrhea include the following:
- Urethral infection: urethral discharge
and/or dysuria (pain with urination)
- Endocervical infection: vaginal discharge
and/or dysuria
- Rectal infection: rectal discharge, rectal
pain, and/or tenesmus (pain with passing
bowel movements)
- Pharyngeal infection: sore throat
If there are no data in the record regarding the
presence OR absence of gonorrhea symptoms as
described above, code this field "9" indicating
"unknown symptomatology."

HISTORY

[Char, 1]

Previous history of
gonorrhea (ever)

1=yes
2=no
9=unknown

Please note any previous documented or selfreported history of gonorrhea in patient's lifetime. If
there is no information concerning history in the
record, code "9" to indicate "unknown."

EPSDS

[Num, 2]

Number of previous
episodes within the
past 12 months

0=no documented episodes
99=unknown

Enter the number of previous episodes of gonorrhea
documented in the patient's record within the past
12 months.

HIVSTAT

[Char, 1]

HIV status at time of
clinic visit for
gonorrhea

1=positive
2=negative
3=indeterminate
9=unknown

Enter patient’s HIV status as known at the time of
the clinic visit for gonorrhea. Code "1" for
"positive" if the patient’s medical record documents
a positive HIV test or if the patient self-reports as
HIV-positive. This can include rapid tests for which
results are available on the day of the clinic visit.
Code "2" for "negative" if the patient’s medical
record documents a negative HIV test within the
previous 3 months. If the available information does

Page 5

Revised January 2021

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name

Type/Length

Description

Values

Comments
not allow you to code "1" or "2," then code "9" for
"unknown.

TRAVEL

[Char, 1]

Travel outside of US
in past 60 days

1=yes
2=no
9=unknown

Code "1" for "yes" if the patient traveled outside of
the United States (50 U.S. states) during the
previous 60 days. Code "2" for "no" if the patient
did not travel internationally during the previous 60
days. If travel information is not available, code "9"
for "unknown."

SEXWK

[Char, 1]

History of giving or
receiving
drugs/money in the
past 12 months

1=yes
2=no
9=unknown

If the patient exchanged drugs or money for sex (or
exchanged sex for drugs or money) during the
previous 12 months, code "1" for "yes." If the
patient did not exchange drugs or money for sex (or
sex for drugs or money), code "2" for "no." If it is
unknown whether the patient had sex work
exposure, code "9" for "unknown." Do not code "2"
for "no" by default.

ANTIBIOT

[Char, 1]

Antibiotic use in the
past 60 days

1=yes
2=no
9=unknown

Code "1" for "yes" if the patient took antibiotics for
any reason during the previous 60 days. This should
only include systemic oral or injectable antibiotics,
and should not include antibiotic ointments or eye
drops. Code "2" for "no" if the patient did not take
antibiotics for any reason during the previous 60
days. If it is unknown whether or not the patient
took antibiotics, code "9" for "unknown." Do not
code "2" for "no" by default.

IDU

[Char, 1]

History of injection
drug use in the past
12 months

1=yes
2=no
9=unknown

Code "1" for "yes" if the patient reported using
recreational injection drugs during the previous 12
months. Code "2" for "no" if the patient reported not
doing recreational injection drugs during the
previous 12 months. If it is unknown whether or not
the patient used recreational injection drugs, code
"9" for "unknown." Do not code "2" for "no" by
default.

NONIDU

[Char, 1]

History of noninjection drug use in

1=yes
2=no

Code "1" for yes if the patient reported using
recreational non-injection drugs during the previous

Page 6

Revised January 2021

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name

Type/Length

Description
the past 12 months

Values
9=unknown

Comments
12 months. Examples: ecstasy, crack, cocaine,
marijuana, methamphetamines, poppers (but
excluding alcohol, medications for erectile
dysfunction, and steroids). Code "2" for "no" if the
patient reported not doing recreational non-injection
drugs during the previous 12 months. If it is
unknown whether or not the patient used
recreational non-injection drugs, code "9" for
"unknown." Do not code "2"
for "no" by default.

TRMT1

[Char, 2]

Primary treatment
for gonorrhea

00=none
03=spectinomycin (Trobicin) 2 gm
04=ceftriaxone (Rocephin) 250 mg
05=ceftriaxone (Rocephin) 125 mg
06=ciprofloxacin (Cipro) 500 mg
07=cefoxitin (Mefoxin) 2 gm
12=cefixime (Suprax) 400 mg
14=cefpodoxime proxetil (Vantin) 200
mg
15=ofloxacin (Floxin) 400 mg
17=ceftizoxime (Cefizox) 500 mg
18=cefotaxime (Claforan) 500 mg
21=azithromycin (Zithromax) 2 gm
22=levofloxacin (Levaquin) 250 mg
23=cefpodoxime proxetil (Vantin) 400
mg
24=ceftibuten (Cedax) 400 mg
25=cefdinir (Omnicef ) 300 mg
26=cefdinir (Omnicef ) 600 mg
27= gemifloxacin 320 mg
28= gentamicin 240 mg (or weightbased dosage)
29=Ceftriaxone 500 mg
30=Ceftriaxone 1g
31=Cefixime 800 mg
88=other (please indicate in Other
Treatment 1)
99=unknown

Indicate the primary antimicrobial prescribed to
treat the case of gonorrhea. If entering the code "88"
for "other," include the name of the drug in the
space provided. If no treatment for gonorrhea was
given, code "00." You must enter both digits of the
treatment code, including leading zeros. Please note
that "01" and "02" are not valid codes.

Page 7

NOTE: The following gonorrhea treatments were
added January 2021.
29: Ceftriaxone 500 mg
30: Ceftriaxone 1g
31: Cefixime 800 mg

Revised January 2021

GISP/eGISP Clinical/Demographic (Epi) Data Elements
Variable Name
OTHTRMT1

Type/Length
[Char, 15]

Description
Other treatment not
listed as code for
TRMT1

Values
If code “88” was entered for Treatment
1, please type in the name and dosage of
the drug used for primary treatment of
gonorrhea.

Comments
If code "88" ("other") was entered for Treatment 1,
write in the name and dosage of the primary
antimicrobial therapy for gonorrhea and dosage that
was administered.

TRMT2

[Char, 2]

Second antibiotic
used as part of dual
therapy for
gonorrhea (and
treatment of
chlamydia)

00=none
01=ampicillin/amoxicillin
09=doxycycline (Vibramycin)/
tetracycline
10=erythromycin
11=azithromycin (Zithromax) 1 gm
15=ofloxacin
21=azithromycin (Zithromax) 2 gm
22=levofloxacin
88=other
99=unknown

In many cases, two antibiotics may be prescribed for
patients diagnosed with gonorrhea. Dual therapy
(treatment with a cephalosporin antibiotic and either
azithromycin or doxycycline) has been
recommended for treatment of gonorrhea since
2010. In addition, patients that are diagnosed with
and treated for gonorrhea are often treated for
chlamydia at the same time. The recommended
therapies for chlamydia are doxycycline and
azithromycin. Seven-day courses of erythromycin,
amoxicillin, levofloxacin, and ofloxacin are
alternatives for selected patients. If dual therapy was
administered, indicate the second antimicrobial
used. If therapy for chlamydia alone was given,
indicate this therapy. Code "88" for other only if the
dual therapy did not include any of the listed
treatment options. You must enter a two-digit code
in this field, including leading zeros.

Page 8

Revised January 2021